Description
The National Institutes of Health (NIMH) is issuing a non‑competitive RFQ to obtain continued bespoke induced pluripotent stem‑cell (iPSC) quality‑control and differentiation services. Vendors will submit price quotations for the required laboratory services, including QC testing and differentiation protocols, with delivery to NIH facilities in Bethesda, MD. The solicitation is open to all qualified suppliers; it is not a small‑business set‑aside. Quotations must be received by 09/02/2026. Evaluation will consider price, technical capability, past performance, and delivery schedule. The contract will be awarded to the offeror providing best value under FAR Part 12.6.
• Service: iPSC QC and differentiation laboratory services
• Location: Bethesda, MD (NIH)
• Quantity/volume: Not specified (service‑based)
• Delivery: Multiple deliveries as needed, FOB destination
• Evaluation criteria: Price, technical capability, past performance, schedule
• Submission deadline: 09/02/2026 (close of business)
• Contact: Brittany May, Contract Specialist (nih.gov)